OS Therapies Inc (OSTX) insider trading

Every open-market stock purchase and sale by OS Therapies Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.

Insider activity at a glance

  • No open-market insider trades in the last 12 months.
  • No open-market insider buys on record.

Last 12 months: insiders bought $0 (0 buys) and sold $0 (0 sales).

Recent OSTX insider trades

DateInsiderTradeValue
Jan 22, 2026Robert Petit (Officer)Bought (not open market)—
Jan 22, 2026Olivier Roger Jarry (Director)Bought (not open market)—
Jan 22, 2026Avril Suzette McKean-Dieser (Director)Bought (not open market)—
Jan 22, 2026Christopher P. Acevedo (CFO)Bought (not open market)—
Jan 22, 2026John Ciccio (Director)Bought (not open market)—
Jan 22, 2026Karim Galzahr (Director)Bought (not open market)—
Jan 22, 2026Theodore F. Search (Director)Bought (not open market)—
Jan 22, 2026Paul A. Romness (CEO)Bought (not open market)—
Oct 21, 2025Karim Galzahr (Director)Bought (not open market)—
Oct 21, 2025Robert Petit (Officer)Bought (not open market)—
Oct 21, 2025Paul A. Romness (CEO)Bought (not open market)—
Oct 21, 2025Theodore F. Search (Director)Bought (not open market)—
Oct 21, 2025John Ciccio (Director)Bought (not open market)—
Oct 21, 2025Christopher P. Acevedo (CFO)Bought (not open market)—
Oct 21, 2025Avril Suzette McKean-Dieser (Director)Bought (not open market)—
Oct 21, 2025Olivier Roger Jarry (Director)Bought (not open market)—
Oct 21, 2025Paul A. Romness (CEO)Bought (not open market)—

Who's trading OSTX

Get free alerts when an insider at OS Therapies Inc files a new trade →